CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in NTRA — Natera, Inc.
CIK 1766904
RICHMOND, VA
Position in NTRA
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$131,107
+$42,514 QoQ
Shares Held
483
+9.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#676
of 844 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $2,270,451 across 11 Diagnostics & Research names. NTRA ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
3,190 | $607,626 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
822 | $412,113 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,059 | $224,451 | |
| 4 | LH |
Labcorp Holdings Inc.
|
684 | $191,520 | |
| 5 | WAT |
Waters Corp /De/
|
445 | $166,890 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
307 | $161,611 | |
| 7 | NTRA |
Natera, Inc.
This page
|
483 | $131,107 | |
| 8 | A |
Agilent Technologies, Inc.
|
978 | $129,904 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,107 | 483 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $88,593 | 443 | Shares | Other | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||